Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
To qualify for weight-management treatment, patients typically need a BMI of 27 or higher, with most programs also considering weight-related health conditions such as high blood pressure, type 2 diabetes, or high cholesterol
Key Takeaways A recent NAD decision underscores that advertising compounded drugs in a way that implies they share the benefits of FDA-approved medications will likely be deemed deceptive by regulators
As of June 2026, the FDA has not approved retatrutide for any indication
Always consult your prescribing physician before adding new over-the-counter acid reducers to your GLP-1 regimen, especially if you are experiencing severe or prolonged side effects
Emerging preclinical research and patient reports suggest GLP-1 medications may influence cravings and consumption patterns for alcohol, tobacco, and other substances
The following variables were associated with declining for waitlisting due to psychosocial reasons: ALD (OR 2.43, 95% CI 1.20-4.93), Black race (1.76, 95% CI 1.10-2.82), Medicaid insurance (OR 2.09, 95% CI 1.31-3.31), and a high risk SIPAT score (OR 6.21, 95% CI 4.08-9.45)
